Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Murray

Showing results (11-20 of 321) with videos related to

Pageof 33
Sort By:
JMIR Medical Informatics|May 9, 2025
Transformer-Based Language Models for Group Randomized Trial Classification in Biomedical Literature: Model Development and ValidationElaheh Aghaarabi, David Murray
International Journal of Molecular Sciences|July 29, 2023
Intratumor Heterogeneity and Treatment Resistance of Solid Tumors with a Focus on Polyploid/Senescent Giant Cancer Cells (PGCCs)Razmik Mirzayans, David Murray
Endocrine Pathology|March 7, 2020
The study of endocrine tumors by flow and image cytometryIngrid Zbieranowski, David Murray
International Journal of Molecular Sciences|December 2, 2020
Do TUNEL and Other Apoptosis Assays Detect Cell Death in Preclinical Studies?Razmik Mirzayans, David Murray
Cell Cycle (Georgetown, Tex.)|July 16, 2015
OCT4A and the DNA damage responseDavid Murray, Razmik Mirzayans
IEEE Transactions on Pattern Analysis and Machine Intelligence|September 24, 2004
Reactive control of zoom while fixating using perspective and affine camerasBen Tordoff, David Murray
Anesthesiology|April 26, 2007
Communication and teamwork: essential to learn but difficult to measureDavid Murray, Cam Enarson
Critical Reviews in Clinical Laboratory Sciences|October 26, 2013
Characterization of immunoglobulin by mass spectrometry with applications for the clinical laboratoryDavid Murray, David Barnidge
International Journal of Molecular Sciences|February 21, 2020
Intratumor Heterogeneity and Therapy Resistance: Contributions of Dormancy, Apoptosis Reversal (Anastasis) and Cell Fusion to Disease RecurrenceRazmik Mirzayans, David Murray
Expert Opinion on Biological Therapy|March 4, 2025
Optimizing biosimilar development: current approaches to demonstrating pharmacokinetic and analytical similarity and a proposal for a single reference approachPeter Kiely, David Murray
Pageof 33

Showing results (11-20 of 321) with videos related to

Sort By:
Pageof 33
JMIR Medical Informatics|May 9, 2025
Transformer-Based Language Models for Group Randomized Trial Classification in Biomedical Literature: Model Development and ValidationElaheh Aghaarabi, David Murray
International Journal of Molecular Sciences|July 29, 2023
Intratumor Heterogeneity and Treatment Resistance of Solid Tumors with a Focus on Polyploid/Senescent Giant Cancer Cells (PGCCs)Razmik Mirzayans, David Murray
Endocrine Pathology|March 7, 2020
The study of endocrine tumors by flow and image cytometryIngrid Zbieranowski, David Murray
International Journal of Molecular Sciences|December 2, 2020
Do TUNEL and Other Apoptosis Assays Detect Cell Death in Preclinical Studies?Razmik Mirzayans, David Murray
Cell Cycle (Georgetown, Tex.)|July 16, 2015
OCT4A and the DNA damage responseDavid Murray, Razmik Mirzayans
IEEE Transactions on Pattern Analysis and Machine Intelligence|September 24, 2004
Reactive control of zoom while fixating using perspective and affine camerasBen Tordoff, David Murray
Anesthesiology|April 26, 2007
Communication and teamwork: essential to learn but difficult to measureDavid Murray, Cam Enarson
Critical Reviews in Clinical Laboratory Sciences|October 26, 2013
Characterization of immunoglobulin by mass spectrometry with applications for the clinical laboratoryDavid Murray, David Barnidge
International Journal of Molecular Sciences|February 21, 2020
Intratumor Heterogeneity and Therapy Resistance: Contributions of Dormancy, Apoptosis Reversal (Anastasis) and Cell Fusion to Disease RecurrenceRazmik Mirzayans, David Murray
Expert Opinion on Biological Therapy|March 4, 2025
Optimizing biosimilar development: current approaches to demonstrating pharmacokinetic and analytical similarity and a proposal for a single reference approachPeter Kiely, David Murray
Pageof 33